NCT02388984

Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy

A Randomized, Double Blind, Multi-Center Study of Compound Danshen Dripping Pills in Patients With Diabetic Retinopathy (Syndrome Of Qi-Stagnation and Blood Stasis)

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 480 (estimated)
• Sponsor: Tasly Pharmaceuticals, Inc. · Industry
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of Compound Danshen Dripping Pills in patients with diabetic retinopathy(Syndrome Of Qi-Stagnation and Blood Stasis).

Detailed description

Compound danshen dripping pills is a kind of traditional Chinese medicine(TCM), consists of Danshen (Radix Salviae Miltiorrhizae), Sanqi (Radix Notoginseng) and borneol. This study is being conducted to evaluate the efficacy and safety of compound danshen dripping pills in patients with diabetic retinopathy(Syndrome Of Qi-Stagnation and Blood Stasis), when compared with placebo.

Conditions

• Non-proliferative Diabetic Retinopathy

Interventions

Type	Name	Description
DRUG	Compound danshen dripping pills	Dosage form:pill. Dosage:20pills. Frequency:three times per day. Duration:24 weeks.
DRUG	Placebo	Dosage form:pill. Dosage:20pills. Frequency:three times per day. Duration:24 weeks.

Timeline

• Start date: 2013-05-01
• Primary completion: 2017-05-01
• Completion: 2017-12-01
• First posted: 2015-03-17
• Last updated: 2017-03-21

Locations

16 sites across 1 country: China